{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:09:02Z","timestamp":1773972542903,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K08399"],"award-info":[{"award-number":["21K08399"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K02681"],"award-info":[{"award-number":["25K02681"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08460"],"award-info":[{"award-number":["22K08460"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K08365"],"award-info":[{"award-number":["18K08365"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.exphem.2025.105350","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T16:07:40Z","timestamp":1765642060000},"page":"105350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Loss of Ezh2 precipitates lethal disease progression in a mouse model of Calr-mutated myeloproliferative neoplasms"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-7035","authenticated-orcid":false,"given":"Koki","family":"Ueda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Minakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6047-2857","authenticated-orcid":false,"given":"Saori","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5269-269X","authenticated-orcid":false,"given":"Kazuhiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.105350_bib0001","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood.2019000622","article-title":"Mutant calreticulin in myeloproliferative neoplasms","volume":"134","author":"How","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0002","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood-2013-11-539098","article-title":"JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes","volume":"123","author":"Rumi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0003","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2025.105350_bib0004","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41408-024-01169-6","article-title":"Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors","volume":"14","author":"Barbui","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2025.105350_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood.2019000943","article-title":"Leukemia secondary to myeloproliferative neoplasms","volume":"136","author":"Dunbar","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/bloodadvances.2016000216","article-title":"Targeted deep sequencing in polycythemia vera and essential thrombocythemia","volume":"1","author":"Tefferi","year":"2016","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2025.105350_bib0007","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","article-title":"Classification and personalized prognosis in myeloproliferative neoplasms","volume":"379","author":"Grinfeld","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2025.105350_bib0008","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1182\/blood-2011-06-363424","article-title":"EZH2 mutational status predicts poor survival in myelofibrosis","volume":"118","author":"Guglielmelli","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0009","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1084\/jem.20151121","article-title":"The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition","volume":"213","author":"Sashida","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2025.105350_bib0010","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20151136","article-title":"Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis","volume":"213","author":"Shimizu","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2025.105350_bib0011","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1182\/blood-2015-11-679431","article-title":"Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm","volume":"127","author":"Yang","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0012","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13045-021-01064-8","article-title":"Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice","volume":"14","author":"Minakawa","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2025.105350_bib0013","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.stem.2015.05.003","article-title":"Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions","volume":"17","author":"Pietras","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.105350_bib0014","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.neuron.2009.08.021","article-title":"Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition","volume":"63","author":"Hirabayashi","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.exphem.2025.105350_bib0015","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood-2015-03-634428","article-title":"Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner","volume":"126","author":"Mochizuki-Kashio","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0016","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s11684-021-0830-0","article-title":"Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.exphem.2025.105350_bib0017","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41467-024-55036-w","article-title":"Pantothenate kinase 4 controls skeletal muscle substrate metabolism","volume":"16","author":"Miranda-Cervantes","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.105350_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100612","article-title":"SCD4 deficiency decreases cardiac steatosis and prevents cardiac remodeling in mice fed a high-fat diet","volume":"65","author":"Wolosiewicz","year":"2024","journal-title":"J Lipid Res"},{"key":"10.1016\/j.exphem.2025.105350_bib0019","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s41588-023-01480-1","article-title":"Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution","volume":"55","author":"Rodriguez-Meira","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.105350_bib0020","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.2415","article-title":"Stem cell gene expression programs influence clinical outcome in human leukemia","volume":"17","author":"Eppert","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2025.105350_bib0021","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3324\/haematol.2019.225003","article-title":"Mutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia","volume":"105","author":"Bill","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.105350_bib0022","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.exphem.2025.105350_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2022.10.003","article-title":"HSC-derived fatty acid oxidation in steady-state and stressed hematopoiesis","volume":"117","author":"Mistry","year":"2023","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2025.105350_bib0024","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.2022017578","article-title":"Genetic basis and molecular profiling in myeloproliferative neoplasms","volume":"141","author":"Luque Paz","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","article-title":"Myeloproliferative neoplasms: a contemporary review","volume":"1","author":"Tefferi","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.exphem.2025.105350_bib0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41408-023-00786-x","article-title":"Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis","volume":"13","author":"Guglielmelli","year":"2023","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2025.105350_bib0027","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood-2017-09-806356","article-title":"Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage","volume":"131","author":"Li","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0028","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41375-019-0538-1","article-title":"Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development","volume":"34","author":"Balligand","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.105350_bib0029","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1038\/s41467-020-18691-3","article-title":"Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN","volume":"11","author":"Benlabiod","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.105350_bib0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1242\/dmm.006817","article-title":"Mouse models of myeloproliferative neoplasms: JAK of all grades","volume":"4","author":"Li","year":"2011","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.exphem.2025.105350_bib0031","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1309\/AJCPUAAC16LIWZMM","article-title":"CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable","volume":"143","author":"Kim","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.exphem.2025.105350_bib0032","doi-asserted-by":"crossref","first-page":"57036","DOI":"10.18632\/oncotarget.10958","article-title":"Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia","volume":"7","author":"Kang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2025.105350_bib0033","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood-2004-07-2864","article-title":"Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases","volume":"105","author":"Mesa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0034","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1182\/blood-2008-02-138230","article-title":"The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms","volume":"112","author":"Tam","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0035","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/ajh.25270","article-title":"Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger","volume":"93","author":"Szuber","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2025.105350_bib0036","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41375-018-0019-y","article-title":"Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts","volume":"32","author":"Tefferi","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.105350_bib0037","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/leu.2017.190","article-title":"Molecular characterization of EZH2 mutant patients with myelodysplastic\/myeloproliferative neoplasms","volume":"31","author":"Rinke","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.105350_bib0038","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/ajh.27013","article-title":"Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms","volume":"98","author":"Calabresi","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2025.105350_bib0039","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.105350_bib0040","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1182\/blood-2011-03-340554","article-title":"Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells","volume":"118","author":"Mochizuki-Kashio","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0041","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/leu.2013.288","article-title":"EZH2 in normal and malignant hematopoiesis","volume":"28","author":"Lund","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.105350_bib0042","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ccell.2015.03.009","article-title":"Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia","volume":"27","author":"Shih","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.105350_bib0043","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ccell.2021.02.006","article-title":"MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism","volume":"39","author":"Ueda","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.105350_bib0044","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1182\/bloodadvances.2017004457","article-title":"Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms","volume":"1","author":"Ueda","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2025.105350_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.105350_bib0046","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1158\/0008-5472.CAN-16-1645","article-title":"Bone marrow adipocytes facilitate fatty acid oxidation activating AMPK and a transcriptional network supporting survival of acute monocytic leukemia cells","volume":"77","author":"Tabe","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2025.105350_bib0047","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.exphem.2025.105350_bib0048","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.stem.2024.11.014","article-title":"Different effects of fatty acid oxidation on hematopoietic stem cells based on age and diet","volume":"32","author":"Merchant","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.105350_bib0049","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPARgamma","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.exphem.2025.105350_bib0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/cr.2010.13","article-title":"PPARs: diverse regulators in energy metabolism and metabolic diseases","volume":"20","author":"Wang","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.exphem.2025.105350_bib0051","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.exphem.2025.105350_bib0052","doi-asserted-by":"crossref","first-page":"C1332","DOI":"10.1152\/ajpcell.90626.2007","article-title":"Specific signals involved in the long-term maintenance of radiation-induced fibrogenic differentiation: a role for CCN2 and low concentration of TGF-beta1","volume":"294","author":"Haydont","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.exphem.2025.105350_bib0053","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15838","article-title":"A Cdc42\/RhoA regulatory circuit downstream of glycoprotein Ib guides transendothelial platelet biogenesis","volume":"8","author":"Dutting","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.105350_bib0054","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2010-04-281428","article-title":"An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model","volume":"119","author":"Bergerson","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105350_bib0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.leukres.2010.06.015","article-title":"Sfpi1\/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription","volume":"35","author":"Brown","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2025.105350_bib0056","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/carcin\/bgv016","article-title":"PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML","volume":"36","author":"Verbiest","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.exphem.2025.105350_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.854973","article-title":"Murine models of acute myeloid leukemia","volume":"12","author":"Kurtz","year":"2022","journal-title":"Front Oncol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25006290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25006290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:17:46Z","timestamp":1773969466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X25006290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":57,"alternative-id":["S0301472X25006290"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105350","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of Ezh2 precipitates lethal disease progression in a mouse model of Calr-mutated myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105350"}}